People

Noel Jee

novoholdings.com

Noel Jee is Director at Route 92 Medical. Life sciences investor and Novo Holdings partner with earlier experience at Sofinnova, Illumina Ventures and L.E.K. Holds a UCSF doctorate in chemistry and chemical biology. Current primary team specifies Venture Investments; historical appointment release said Growth Investments. Noel Jee is a Partner in the Venture Investments team at Novo Holdings based in San Francisco. Noel contributes a balance of investment acumen for evaluating life science investment opportunities, strategic advisory, and operational support skills for portfolio companies. Previously an investor with Sofinnova Investments and Illumina Ventures, Noel honed his investment experience across therapeutics, life science tools, diagnostics, and healthcare platforms. Noel’s time at Illumina Ventures also included 10 months operating a portfolio company. Prior to his time in venture capital, he was a management consultant at L.E.K. Consulting where he advised large and small-cap biopharma and diagnostics companies on a variety of strategic projects, from asset M&A to pipeline prioritization and expansion. Noel received his PhD in Chemistry and Chemical Biology from the University of California, San Francisco. Noel also holds a B.S. in Biochemistry and a B.S. in Neurobiology and Physiology from the University of Maryland, College Park.